サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1452635

中南米の細胞・遺伝子治療向け製造サービス：2030年までの市場予測 - 地域別分析 - タイプ別、適応症別、用途別、エンドユーザー別

South & Central America Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type, Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 92 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
中南米の細胞・遺伝子治療向け製造サービス：2030年までの市場予測 - 地域別分析 - タイプ別、適応症別、用途別、エンドユーザー別
出版日: 2024年01月15日
発行: The Insight Partners
ページ情報: 英文 92 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の細胞・遺伝子治療向け製造サービス市場は、2022年の2億8,683万米ドルから2030年には9億8,118万米ドルに成長すると予測されています。2022年から2030年までのCAGRは16.6%と推定されます。

細胞・遺伝子治療向け製造のアウトソーシング人気の高まりが中南米の細胞・遺伝子治療向け製造サービス市場を牽引

細胞・遺伝子治療向け製造は複雑なプロセスであるため、業務の適切な実行と監督が極めて重要です。細胞・遺伝子治療メーカーは、生物学やプロセス工学に精通した有資格者の数が限られています。さらに、経験豊富なチームにとって、手作業でオープンな製造方法を用いて最初の臨床試験に到達する試みを管理し、その後、より商業的に適したプロセスを構築することは厄介なことです。そのため、これらの企業は、臨床試験と商業化プロセスを加速するために、開発・製造受託機関（CDMO）との協力を選択します。CDMOは、製品開発、製造、臨床試験サポート、商業化サービスを細胞・遺伝子治療企業に契約ベースで提供します。CDMOと提携することで、細胞・遺伝子治療メーカーにとって、スケーラビリティ、市場投入までのスピード、オーバーヘッドコストのない技術的専門知識へのアクセス、コストの効率化が可能になります。さらに2020年3月、富士フイルムセルラー・ダイナミクス（FCDI）はcGMP準拠の製造施設に2,100万米ドルを投資しました。この施設は、人工多能性幹細胞（iPSC）を用いたFCDIの再生医療パイプラインの製造に使用され、iPSCおよびiPSC由来の分化細胞の製造のためのCDMOサービスを提供します。細胞治療や遺伝子治療の製造をCDMOに委託することは、メーカーにとって費用対効果が高いです。さらに、技術的に高度なインフラとCDMOの専門知識を利用することができます。CDMOは、細胞・遺伝子治療薬の製造に適切でマッピングされたプロセスを採用しています。このように、成長を続ける細胞・遺伝子治療向け製造のCDMOへのアウトソーシング志向の高まりが、中南米の細胞・遺伝子治療向け製造サービス市場の成長を後押ししています。

中南米の細胞・遺伝子治療向け製造サービス市場概要

Law Business Research 2020が発行したレポート「First Gene Therapy Products Approved in Brazil」によると、ブラジルはラテンアメリカ諸国の中で最初に遺伝子治療製品の販売を承認した国です。具体的には、ブラジル保健規制庁（ANVISA）がノバルティスの遺伝子治療製品LuxturnaとZolgensmaの販売承認を与えました。両製品とも、ブラジルにおける遺伝子組換え生物の生物学的安全性を評価するブラジル生物学的安全性技術委員会（CTNBio）の承認を得ています。クリニカル・トライアルズ・アリーナによると、2021年、ブラジルは世界の臨床試験活動の1.7％のシェアを占めています。2022年7月、ボストンCROはリオデジャネイロを拠点とするブラジル臨床試験研究所（IBPClin）を買収し、ラテンアメリカで分散型臨床試験提供モデルを採用する第一歩となったとしています。IBPClinは、ブラジルの12州で7,000人以上の参加者を登録し、160以上の産業界主催の調査を実施したとしています。

中南米の細胞・遺伝子治療向け製造サービス市場の収益と2030年までの予測（金額）

中南米の細胞・遺伝子治療向け製造サービス市場のセグメンテーション

中南米の細胞・遺伝子治療向け製造サービス市場は、タイプ、適応症、用途、エンドユーザー、国に区分されます。

タイプ別では、中南米の細胞・遺伝子治療向け製造サービス市場は細胞治療と遺伝子治療に二分されます。2022年、中南米の細胞・遺伝子治療向け製造サービス市場では、細胞治療分野が大きなシェアを記録しました。細胞療法分野はさらに自己由来と同種異系に区分されます。遺伝子治療分野はさらにウイルスベクターと非ウイルスベクターに区分されます。

適応症に基づき、中南米の細胞・遺伝子治療向け製造サービス市場はがん、整形外科、その他に区分されます。2022年、中南米の細胞・遺伝子治療向け製造サービス市場では、がん分野が最大のシェアを記録しました。

用途別では、中南米の細胞・遺伝子治療向け製造サービス市場は臨床製造と商業製造に区分されます。2022年には、商業用製造セグメントが中南米の細胞・遺伝子治療向け製造サービス市場で最大のシェアを記録しました。

エンドユーザーに基づき、中南米の細胞・遺伝子治療向け製造サービス市場は製薬・バイオテクノロジー企業と契約研究機関（CRO）に二分されます。2022年、中南米の細胞・遺伝子治療向け製造サービス市場では、製薬・バイオテクノロジー企業セグメントが大きなシェアを記録しました。

国別に見ると、中南米の細胞・遺伝子治療向け製造サービス市場は、ブラジル、アルゼンチン、その他南米に区分されます。2022年には、ブラジルが中南米の細胞・遺伝子治療向け製造サービス市場で最大のシェアを記録しました。

Catalent Inc、Charles River Laboratories International Inc、Lonza Group AG、Merck KgaA、Nikon Corp、Takara Bio Inc、Thermo Fisher Scientific Incは、中南米の細胞・遺伝子治療向け製造サービス市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の細胞・遺伝子治療向け製造サービス市場：主要産業力学

  • 主な市場促進要因
    • 細胞・遺伝子治療の承認件数の増加
    • 細胞・遺伝子治療向け製造アウトソーシングの人気上昇
  • 市場抑制要因
    • 細胞・遺伝子治療向け製造の高コスト
  • 市場機会
    • 企業による戦略的取り組み
  • 今後の動向
    • 細胞・遺伝子治療向け製造サービスの自動化
  • インパクト分析

第5章 細胞・遺伝子治療向け製造サービス市場：中南米市場分析

  • 中南米の細胞・遺伝子治療向け製造サービス市場収益、2022年～2030年

第6章 中南米の細胞・遺伝子治療向け製造サービス市場：収益と2030年までの予測 - タイプ別

  • 細胞療法
  • 遺伝子治療

第7章 中南米の細胞・遺伝子治療向け製造サービス市場：分析と2030年までの予測 - 適応症別

  • がん
  • 整形外科
  • その他

第8章 中南米の細胞・遺伝子治療向け製造サービス市場：収益と2030年までの予測 - 用途別

  • 臨床製造
  • 商業用製造

第9章 中南米の細胞・遺伝子治療向け製造サービス市場：収益と2030年までの予測 - エンドユーザー別

  • 製薬企業およびバイオテクノロジー企業
  • CRO（医薬品開発業務受託機関）

第10章 中南米の細胞・遺伝子治療向け製造サービス市場：収益と2030年までの予測 - 国別分析

    • 中南米
      • ブラジル
      • アルゼンチン
      • その他中南米

第11章 中南米の細胞・遺伝子治療向け製造サービス市場：業界情勢

  • 中南米の細胞・遺伝子治療向け製造サービス市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Charles River Laboratories International Inc
  • Lonza Group AG
  • Catalent Inc
  • Takara Bio Inc
  • Nikon Corp
図表

List Of Tables

  • Table 1. South & Central America Cell and Gene Therapy Manufacturing Services Market Segmentation
  • Table 2. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
  • Table 3. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
  • Table 4. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
  • Table 5. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
  • Table 6. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
  • Table 7. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
  • Table 8. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
  • Table 9. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
  • Table 10. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
  • Table 11. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
  • Table 12. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
  • Table 13. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
  • Table 14. Rest of South and Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
  • Table 15. Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
  • Table 16. Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
  • Table 17. Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
  • Table 18. Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
  • Table 19. Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
  • Table 20. Recent Organic Growth Strategies in South & Central America Cell and Gene Therapy Manufacturing Services Market
  • Table 21. Recent Inorganic Growth Strategies in the South & Central America Cell and Gene Therapy Manufacturing Services Market

List Of Figures

  • Figure 1. South & Central America Cell and Gene Therapy Manufacturing Services Market Segmentation, By Country
  • Figure 2. South & Central America Cell and Gene Therapy Manufacturing Services Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 6. Cell Therapy: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Autologous: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Allogenic: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Gene Therapy: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Viral Vector: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Non-Viral Vector: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication 2022 & 2030 (%)
  • Figure 13. Cancer: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Orthopedics: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 17. Clinical Manufacturing: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Commercial Manufacturing: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 20. Pharmaceutical & Biotechnology Companies: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Contract Research Organizations (CROs): South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Key Region - Revenue (2022) (US$ Million)
  • Figure 23. South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Country, 2022 & 2030 (%)
  • Figure 24. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Growth Strategies in South & Central America Cell and Gene Therapy Manufacturing Services Market
目次
Product Code: BMIRE00029316

The South & Central America cell and gene therapy manufacturing services market is expected to grow from US$ 286.83 million in 2022 to US$ 981.18 million by 2030. It is estimated to grow at a CAGR of 16.6% from 2022 to 2030.

Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing Drives South & Central America Cell and Gene Therapy Manufacturing Services Market

Cell and gene therapy manufacturing is a complex process, which makes the proper execution and overseeing of the operation crucial. Cell and gene therapy manufacturers have a limited number of qualified personnel who know biological and process engineering. Moreover, for experienced teams, managing the attempts to reach the first clinical trial using a manual, and open manufacturing method and then building a more commercially suitable process can be tricky. Therefore, these enterprises choose to work with contract development and manufacturing organizations (CDMOs) to accelerate their clinical studies and commercialization process. CDMOs provide product development, manufacturing, clinical trial support, and commercialization services to cell and gene therapy companies on a contract basis. Partnering with a CDMO enables scalability, speed to market, access to technical expertise without overhead costs, and cost efficiencies for cell and gene therapy manufacturers. Further, in March 2020, Fujifilm Cellular Dynamics (FCDI) invested US$ 21 million in the cGMP-compliant production facility, which would be used for manufacturing FCDI's pipeline of regenerative medicine therapies using induced pluripotent stem cells (iPSCs) and to provide CDMO services for production of iPSCs and iPSC-derived differentiated cells. Outsourcing cell and gene therapy manufacturing to CDMOs proves cost-effective for manufacturers. Moreover, they gain access to the technologically advanced infrastructure and expertise of CDMOs. CDMOs employ proper, mapped processes for manufacturing cell and gene therapies. Thus, the increasing preference for outsourcing growing cell and gene therapy manufacturing to CDMOs fuels the South & Central America cell and gene therapy manufacturing services market growth.

South & Central America Cell and Gene Therapy Manufacturing Services Market Overview

According to a report titled "First Gene Therapy Products Approved in Brazil," published by Law Business Research 2020, Brazil is the first among the Latin American countries to approve the marketing of gene therapy products. Specifically, the Brazilian Health Regulatory Agency (ANVISA) granted marketing authorization for Novartis' gene therapy products Luxturna and Zolgensma. Both products have been approved by the Brazilian Technical Commission of Biosafety (CTNBio), which is responsible for evaluating the biosafety of genetically modified organisms in Brazil. According to Clinical Trials Arena, in 2021, Brazil accounted for a 1.7% share of the global clinical trials activity. In July 2022, Boston CRO acquired Rio de Janeiro-based Instituto Brasil de Pesquisa Clinica (IBPClin), describing it as the first step toward adopting its decentralized clinical trial delivery model in Latin America. It claims to have conducted more than 160 industry-sponsored research studies, enrolling more than 7,000 participants across 12 Brazilian states.

South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Cell and Gene Therapy Manufacturing Services Market Segmentation

The South & Central America cell and gene therapy manufacturing services market is segmented into type, indication, application, end user, and country.

Based on type, the South & Central America cell and gene therapy manufacturing services market is bifurcated into cell therapy and gene therapy. In 2022, the cell therapy segment registered a larger share in the South & Central America cell and gene therapy manufacturing services market. The cell therapy segment is further segmented into autologous and allogenic. The gene therapy segment is further segmented into viral and non-viral vector.

Based on indication, the South & Central America cell and gene therapy manufacturing services market is segmented into cancer, orthopedics, and others. In 2022, the cancer segment registered the largest share in the South & Central America cell and gene therapy manufacturing services market.

Based on application, the South & Central America cell and gene therapy manufacturing services market is segmented into clinical manufacturing and commercial manufacturing. In 2022, the commercial manufacturing segment registered the largest share in the South & Central America cell and gene therapy manufacturing services market.

Based on end user, the South & Central America cell and gene therapy manufacturing services market is bifurcated into pharmaceutical and biotechnology companies and contract research organization (CROs). In 2022, the pharmaceutical and biotechnology companies segment registered a larger share in the South & Central America cell and gene therapy manufacturing services market.

Based on country, the South & Central America cell and gene therapy manufacturing services market is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2022, Brazil registered the largest share in the South & Central America cell and gene therapy manufacturing services market.

Catalent Inc, Charles River Laboratories International Inc, Lonza Group AG, Merck KgaA, Nikon Corp, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America cell and gene therapy manufacturing services market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Cell and Gene Therapy Manufacturing Services Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increase in Number of Approval of Cell and Gene Therapies
    • 4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Cell and Gene Therapy Manufacturing
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Companies
  • 4.4 Future Trends
    • 4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 4.5 Impact Analysis:

5. Cell and Gene Therapy Manufacturing Services Market - South & Central America Market Analysis

  • 5.1 South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - by Type

  • 6.1 Overview
  • 6.2 South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)
  • 6.3 Cell Therapy
    • 6.3.1 Overview
    • 6.3.2 Cell Therapy: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Autologous
        • 6.3.2.1.1 Overview
        • 6.3.2.1.2 Autologous: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.2 Allogenic
        • 6.3.2.2.1 Overview
        • 6.3.2.2.2 Allogenic: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Gene Therapy
    • 6.4.1 Overview
    • 6.4.2 Gene Therapy: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 Viral Vector
        • 6.4.2.1.1 Overview
        • 6.4.2.1.2 Viral Vector: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.2 Non-Viral Vector
        • 6.4.2.2.1 Overview
        • 6.4.2.2.2 Non-Viral Vector: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Cell and Gene Therapy Manufacturing Services Market Analysis and Forecasts to 2030 - by Indication

  • 7.1 Overview
  • 7.2 South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication 2022 & 2030 (%)
  • 7.3 Cancer
    • 7.3.1 Overview
    • 7.3.2 Cancer: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Orthopedics
    • 7.4.1 Overview
    • 7.4.2 Orthopedics: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.4 Clinical Manufacturing
    • 8.4.1 Overview
    • 8.4.2 Clinical Manufacturing: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Commercial Manufacturing
    • 8.5.1 Overview
    • 8.5.2 Commercial Manufacturing: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.4 Pharmaceutical and Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Pharmaceutical & Biotechnology Companies: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Contract Research Organizations (CROs)
    • 9.5.1 Overview
    • 9.5.2 Contract Research Organizations (CROs): South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 Overview
    • 10.1.1 South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Country, 2022 & 2030 (%)
      • 10.1.1.1 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
        • 10.1.1.1.1.1 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
        • 10.1.1.1.1.2 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
        • 10.1.1.1.2 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
        • 10.1.1.1.3 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.4 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.2 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
        • 10.1.1.2.1.1 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
        • 10.1.1.2.1.2 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
        • 10.1.1.2.2 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
        • 10.1.1.3.1.1 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
        • 10.1.1.3.1.2 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
        • 10.1.1.3.2 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
        • 10.1.1.3.3 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)

11. South & Central America Cell and Gene Therapy Manufacturing Services Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in South & Central America Cell and Gene Therapy Manufacturing Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Merck KGaA
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Charles River Laboratories International Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Lonza Group AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Catalent Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Takara Bio Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Nikon Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments